SCHEMBL6997201

SCHEMBL6997201

Fc1ccc(Nc2ncnc3cnc(NCCCN4CCOCC4)nc23)cc1Cl

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 15/20 0.71
ERBB2 P04626 4/20 0.59
HPGD P15428 1/20 0.59
HTT P42858 1/20 0.59
BRAF P15056 5/20 0.57
CIT O14578 1/20 0.57
GAK O14976 1/20 0.57
EPHB6 O15197 1/20 0.57
ABCC4 O15439 1/20 0.57
DAPK3 O43293 1/20 0.57
RIPK2 O43353 1/20 0.57
NR1I2 O75469 1/20 0.57
RPS6KA4 O75676 1/20 0.57
STK17B O94768 1/20 0.57
STK10 O94804 1/20 0.57
PRKD3 O94806 1/20 0.57
ABCB11 O95342 1/20 0.57
MAP4K4 O95819 1/20 0.57
CHEK2 O96017 1/20 0.57
ABL1 P00519 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8317682 0.95 EGFR (0.70) EGFRERBB2HPGDHTTBRAF
SCHEMBL8312893 0.87 EGFR (0.64) EGFRERBB2HPGDHTTMAPT
SCHEMBL8318613 0.87 EGFR (0.73) EGFRERBB2HPGDHTTBRAF
SCHEMBL6990172 0.86 EGFR (0.59) EGFRERBB2HPGDHTTBRAF
SCHEMBL6994799 0.86 EGFR (0.53) EGFRERBB2HPGDHTTBRAF
SCHEMBL8317451 0.85 EGFR (0.69) EGFRERBB2HPGDHTTBRAF
SCHEMBL7577674 0.85 EGFR (0.56) EGFRERBB2HPGDHTTBRAF
SCHEMBL6997407 0.84 EGFR (0.61) EGFRERBB2HPGDHTTBRAF
SCHEMBL6989432 0.84 STK17A (0.62) EGFRERBB2HPGDHTTSTK17B
SCHEMBL8319342 0.84 EGFR (0.58) EGFRERBB2HPGDHTTBRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888351-A1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION Dr. Karl Thomae GmbH (DE) 1999-01-07 EP claimed
WO-1997032880-A1 PYRIMIDO[5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION DR. KARL THOMAE GMBH (DE) 1997-09-12 WO claimed
EP-0888351-B1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION THOMAE GMBH DR K (DE) 2003-10-15 EP disclosed
EP-0779888-B1 PYRIMIDO [5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM BOEHRINGER INGELHEIM PHARMA (DE) 1999-04-28 EP disclosed
EP-0888351-A1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION Dr. Karl Thomae GmbH (DE) 1999-01-07 EP disclosed
WO-1997032880-A1 PYRIMIDO[5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION DR. KARL THOMAE GMBH (DE) 1997-09-12 WO disclosed